KIDS
$17.21
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
Intraday
Recent News
OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?
OrthoPediatrics (KIDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 32.7% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
OrthoPediatrics Corp. Q4 2025 Earnings Call Summary
Moby summary of OrthoPediatrics Corp.'s Q4 2025 earnings call
OrthoPediatrics Corp (KIDS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
OrthoPediatrics Corp (KIDS) closes 2025 with a 17% revenue increase and positive free cash flow, while navigating increased expenses and competitive pressures.
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.